Business Intelligence

Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.

House lawmakers want to relax ban on physician-owned hospitals

The bipartisan Physician Led and Rural Access to Quality Care Act would amend the Social Security Act to allow physicians to open new hospitals in hard-to-reach communities.

Medicare Money dollar payment reimbursement

Humana buys stake in Healthpilot to expand Medicare Advantage portfolio

Healthpilot will remain an independent, payer-agnostic company despite Humana’s minority stake.

Thumbnail

Nationwide IT outage leaves hospitals without EHRs

Many hospitals that use Epic were unable to access services, forcing them to operate on pen-and-paper and cancel non-emergency care delivery. The disruption was caused by an error with security vendor CrowdStrike.

healthcare money economics dollar stethoscope acquire merger

Private equity firms back less than 4% of healthcare providers, report finds

According to an analysis from PitchBook, providers backed by private equity make up only 3.3% of the total market by revenue.

Department of Justice DOJ

DOJ investigating Steward Health Care over ties to foreign government

Citing two sources familiar with the matter, journalists at CBS News said the health system is suspected of violating the Foreign Corrupt Practices Act. No charges have been filed.

'Well-resourced and innovation-focused hospitals should mentor and provide technical support to underfunded or smaller hospitals.'

How to mitigate institutional inequities involving AI

When it comes to adopting healthcare AI, large, well-off hospitals are likely to frequently homer while smaller, struggling institutions go down looking. (Baseball analogy in honor of tonight’s Midsummer Classic.) 

Eli Lilly

Eli Lilly purchases Morphic and its Crohn's drug portfolio for $3.2B

Morphic's new treatment for inflammatory bowel disease is in Phase II clinical trials and shows promise in improving patient outcomes. Eli Lilly will purchase the company for $57 per share in cash.

Thumbnail

Insurers accused of $50B fraud connected to Medicare Advantage plans

According to a report, from 2019 and 2021, Medicare Advantage plans put taxpayers on the hook for dubious care services.

Around the web

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Trimed Popup
Trimed Popup